Linden Advisors »

Travere Therapeutics shares owned by Linden Advisors

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Linden Advisors from 13F filings

Historical chart of Linden Advisors investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Linden Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Linden Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $963M 1.5M 645.12
2023-06-30 $11B 14M 812.25
2023-03-31 $29M 29M 0.98
2022-03-31 $21M 20M 1.06